Lipid Formulation Strategies for Enhancing Intestinal Transport and Absorption of P-Glycoprotein (P-gp) Substrate Drugs: In vitro/In vivo Case Studies-Reference-Cited by-同舟云学术

Lipid Formulation Strategies for Enhancing Intestinal Transport and Absorption of P-Glycoprotein (P-gp) Substrate Drugs: In vitro/In vivo Case Studies

Published:2007-02 Issue:2 Volume:96 Page:235-248
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Constantinides Panayiotis P.,Wasan Kishor M.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference56 articles.

1. Recent progress in P-glycoprotein research;Ueda;Anticancer Drug Design,1999

2. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption;Hunter;Adv Drug Del Rev,1997

3. P-glycoprotein inhibitors and their screening: A perspective from bioavailability enhancement;Varma;Pharmacol Res,2003

4. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter;Romsicki;Biochemistry,1999

5. Is the multidrug transporter a flippase?;Higgins;Trends Biochem Sci,1992

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cimicifugoside H-2 as an Inhibitor of IKK1/Alpha: A Molecular Docking and Dynamic Simulation Study;Biomolecules;2024-07-17

2. Virtual screening, ADME prediction, drug-likeness, and molecular docking analysis of Fagonia indica chemical constituents against antidiabetic targets;Molecular Diversity;2024-07-16

3. A comprehensive molecular docking-based study to identify potential drug-candidates against the novel and emerging severe fever with thrombocytopenia syndrome virus (SFTSV) by targeting the nucleoprotein;The Nucleus;2024-05-22

4. Exploring the potential of P-glycoprotein inhibitors in the targeted delivery of anti-cancer drugs: A comprehensive review;European Journal of Pharmaceutics and Biopharmaceutics;2024-05

5. Pharmacokinetics and pharmacodynamics of cyclodextrin-based oral drug delivery formulations for disease therapy;Carbohydrate Polymers;2024-04